Delivery Order SPE2DR25D2101-SPE2DR26F45ZN
- Not listed
- The Defense Logistics Agency awarded a $1,546.46 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg on December 5, 2025, with completion scheduled for December 8, 2025. This competitively awarded, firm fixed-price contract reflects a small-value pharmaceutical transaction typical of the company's extensive federal medical supply portfolio. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $12,606.73 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) on December 8, 2025, with completion scheduled for December 9, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competitive procurement. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $1,902.96 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) on December 5, 2025, with a completion date of December 8, 2025. This non-competitive, firm fixed-price delivery order represents a routine pharmaceutical procurement under the company's broader federal contract portfolio. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order valued at $2,268.58 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. This non-competitive, firm fixed price delivery order was awarded on November 6, 2025, with an ultimate completion date of November 7, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,533.97 for 60 tablets of Eliquis 5 mg on August 18, 2025, with completion scheduled for August 19, 2025. This is a firm fixed price, non-set-aside contract utilizing a competitive award process. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $23,834.83 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60-tablet units of Eliquis 5 mg on December 2, 2025, with completion scheduled for December 3, 2025. This non-set-aside competitive award represents a pharmaceutical supply delivery to support federal medical procurement needs. The order is being fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,487.31 on December 4, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). This competitively awarded, firm fixed-price contract carries an ultimate completion date of December 5, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $24,927.60 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg on December 8, 2025, with completion scheduled for December 9, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The company, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $14,369.11 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) on November 24, 2025, with a completion date of November 25, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a small-value transaction under AmerisourceBergen's larger pharmaceutical supply relationship with DLA. The pharmaceutical will be delivered to the contractor's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, valued at $4,810.79, with an ultimate completion date of November 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded on a competitive basis. The pharmaceutical product will be delivered to the contractor's place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F45ZNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,208.58 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg on December 1, 2025, with completion scheduled for December 2, 2025. This competitive award, issued under a firm fixed-price contract type with no set-aside designation, represents a small-value pharmaceutical procurement supporting federal medical supply requirements. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated consistent capability to fulfill federal procurement requirements through competitive awards across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 11/30/25 |